You are here

Company Monitoring Page for Takeda

latest headlines for company on cafepharma

Takeda puts $510M on the line to expand KSQ cancer collaboration

Fierce Biotech

Wed, 05/17/23 - 10:09 am

Tags:

Takeda, KSQ Therapeutics, cancer, oncology

Big Pharma layoffs: BMS, Roche and Takeda axe hundreds of jobs

Medical Marketing and Media

Mon, 05/15/23 - 10:04 am

Tags:

layoffs, Bristol Myers Squibb, Roche, Takeda, Gossamer Bio, Novavax

Takeda cuts 2 midstage GI assets including Crohn's hopeful in latest pipeline cleanup

Fierce Biotech

Thu, 05/11/23 - 11:02 am

Tags:

Takeda, R&D, gene therapy, earnings, Crohn’s disease

Gout Disease Control Suffered After FDA-Driven Price Hike: Study

BioSpace

Thu, 05/11/23 - 10:01 am

Tags:

FDA, gout, colchicine, drug pricing, Takeda, Colcrys

Takeda Cuts 180+ Jobs Amid Pipeline Shake-Up

BioSpace

Mon, 05/8/23 - 11:48 pm

Tags:

Takeda, layoffs, Massachusetts

Takeda tries again with subcutaneous Entyvio

Pharmaphorum

Fri, 04/28/23 - 10:02 am

Tags:

Takeda, Entyvio, ulcerative colitis

Takeda taps Innate for a new celiac approach

EP Vantage

Thu, 04/13/23 - 09:58 am

Tags:

Takeda, celiac disease, Innate Pharma, antibody-drug conjugate

Takeda hit with another pay-for-delay lawsuit, this time on gout drug Colcrys

Fierce Pharma

Wed, 04/12/23 - 10:07 pm

Tags:

Takeda, pay-for-delay, generics, gout, Colcrys

Layoffs loom as Takeda trims early-stage efforts in AAV gene therapy, rare hematology

Fierce Biotech

Fri, 04/7/23 - 01:45 pm

Tags:

Takeda, R&D, gene therapy, hematology

Takeda opens 4th front in assault on celiac, tapping Innate to develop antibody-drug conjugates

Fierce Biotech

Mon, 04/3/23 - 09:44 am

Tags:

Takeda, celiac disease, antibody-drug conjugate, Innate Pharma

Go or no go? Seagen's Padcev eyes FDA approval

EP Vantage

Mon, 04/3/23 - 09:41 am

Takeda invests $760M+ into new plasma-derived therapy manufacturing site in Japan

Endpoints

Thu, 03/23/23 - 08:54 pm

Tags:

Takeda, Japan, plasma therapy, drug manufacturing

Takeda, chasing Bristol Myers, unveils awaited TYK2 drug data

BioPharma Dive

Sun, 03/19/23 - 01:46 pm

Tags:

Takeda, Bristol Myers Squibb, clinical trials, TAK-279, plaque psoriasis

Takeda’s Vedolizumab Clears Phase III in aGvHD

BioSpace

Tue, 02/21/23 - 10:03 am

Tags:

Takeda, vedolizumab, graft vs host disease, clinical trials

Takeda's Iclusig shows potential to become standard of care in acute lymphoblastic leukemia subtype

Fierce Pharma

Wed, 02/15/23 - 06:16 pm

Tags:

Takeda, Iclusig, acute lymphoblastic leukemia, ALL, ASCO

Japan cancels 140M dose order for Novavax Covid vaccine amid 'lower than expected' demand

Endpoints

Sun, 02/12/23 - 07:44 pm

Tags:

Japan, Novavax, COVID-19, vaccines, Takeda

Takeda focuses on ‘diverse’ pipeline prospects on heels of two acquisitions

Endpoints

Mon, 02/6/23 - 10:55 am

Tags:

Takeda, Nimbus Therapeutics, Hutchmed, colorectal cancer, psoriasis, fruquintinib

Q4 earnings roundup: Merck, Lilly, Takeda and BMS release financials

Medical Marketing and Media

Thu, 02/2/23 - 10:55 am

Tags:

earnings, Merck, Takeda, Bristol Myers Squibb, Eli Lilly

The world's twelfth VEGF drug will be sold by Takeda

EP Vantage

Mon, 01/23/23 - 10:43 am

Tags:

Takeda, Hutchmed, VEGF, fruquintinib

Biopharma's stock market winners of 2022 revealed

EP Vantage

Wed, 01/18/23 - 09:46 am

Tags:

pharma stocks, Merck, Eli Lilly, AbbVie, Daiichi Sankyo, Vertex Pharmaceuticals, Takeda, Sarepta Therapeutics, Halozyme, Horizon Therapeutics

Pages

last 30 twitter posts